Brigitte Schmittlein
Papers
1
Total Citations
12
H-Index
1
About
Brigitte Schmittlein is a leading figure in the field of automated biomanufacturing, with a specialized focus on scalable cell therapy production. Her most-cited work, "Development of a robotic cluster for automated and scalable cell therapy manufacturing" (2024), has already garnered 12 citations, signaling its rapid influence on the industry. Schmittlein’s primary contribution lies in integrating robotics and process control to overcome critical bottlenecks in cell therapy manufacturing—specifically, the transition from manual, labor-intensive protocols to reproducible, high-throughput automated systems. Her research addresses the pressing need for cost-effective, GMP-compliant production of cell-based therapeutics, enabling broader clinical access. By designing robotic clusters that handle complex tasks like cell culture, harvesting, and quality control, she has laid the groundwork for next-generation manufacturing platforms. This work not only advances the field of bioprocess engineering but also holds transformative potential for personalized medicine, making her a key innovator in bridging laboratory research and clinical application.
Research Focus
Key Achievements
Top Papers
- 1